The George Institute India’s large-scale community-based model demonstrates reduced depression, self-harm, and suicide risk among adolescents in Delhi and Vijayawada
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries
Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada
The twin designations are designed to speed up the development and review of promising medicines targeting serious conditions with high unmet need
The association is intended to strengthen healthcare delivery standards, particularly in Oncology services, and enhance patient care outcomes
Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis
The agreement could rise to $900 million if key commercial milestones are met
The Danish biotech company confirmed the global study will begin in the second half of 2026
SPARC enters definitive agreement to monetise rare paediatric disease PRV, unlocking capital for R&D and strategic growth
Subscribe To Our Newsletter & Stay Updated
